German Health Reform Bill Amendment

25 November 1996

German Health Minister Horst Seehofer has agreed to change a controversial feature of the third draft health service reform legislation, permitting health funds to increase their premiums without a corresponding rise in patient contributions to the cost of their drugs, medicines and treatment.

Meantime, Rudolf Dressler, chairman of the Social Democratic Party's parliamentary committee, says the third-phase reform will lead to a "drastic rise in costs." He says the current health fund deficit will have topped 14 billion Deutschemarks ($9.37 billion) by the end of 1996, making "massive increases in premiums" unavoidable for most funds in 1997.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight